Share
Share this article
Copy linkX (Twitter)LinkedInFacebookEmail
Finance
Share
Share this article
Copy linkX (Twitter)LinkedInFacebookEmail
Former Brazil central bank official unveils
Finance
Share
Share this article
Copy linkX (Twitter)LinkedInFacebookEmail
Former Brazil central bank official unveils
Former Brazil central bank official unveils real-pegged stablecoin with yield sharing
Former Brazil central bank official unveils real-pegged stablecoin with yield sharing
The stablecoin will be backed by Brazil's National Treasury bonds and offer exposure to the country's interest rate, currently 15%.
By Francisco Rodrigues|Edited by Sheldon Reback
Jan 7, 2026, 2:14 p.m.
Make us preferred on Google
A former central bank official announced a Brazilian real-pegged stablecoin. (Rafaela Biazi/Unsplash/Modified by CoinDesk)
What to know:
- Tony Volpon, a former director at Brazil's central bank, announced BRD, a stablecoin backed by Brazilian government debt, aiming to give foreign investors access to the country's high-yield environment.
- The stablecoin will be backed by Brazil's National Treasury bonds and offer exposure to the country's interest rates, currently 15%.
- The token could also support demand for Brazilian debt, potentially lowering government borrowing costs, and is expected to attract institutional investors seeking high-yield returns.
Tony Volpon, a former director at the Central Bank of Brazil, unveiled BRD, a yield-sharing stablecoin tied to the Brazilian currency and backed by Brazilian government debt.
Speaking on the “Cripto na Real” program on CNN Brasil, Volpon said the token will be backed by National Treasury bonds, linking its value to sovereign debt and aiming to give holders exposure to local interest rates. The central bank's benchmark interest rate is 15%, compared with the Federal Reserve's target of 3.5%-3.75%.
STORY CONTINUES BELOW
Don't miss another story.Subscribe to the Crypto Daybook Americas Newsletter today. See all newsletters
Sign me up
Volpon said the goal is to make Brazil’s high-yield environment more accessible to foreign investors. While Brazil’s interest rates have long drawn international attention, he said, access to these returns is often limited by regulation, currency friction and domestic infrastructure.
“The ability to remunerate stablecoin holders with the interest rates offered by Brazil will obviously be a major draw, especially for institutional investors,” Volpon said during the program.
The former central bank official also suggested that the stablecoin could support demand for the country's debt, potentially lowering borrowing costs by expanding the investor base.
BRD will enter a market dominated by Transfero’s BRZ, which commands an $185 million market capitalization. Other competitors include BBRL, with a $51 million market cap, as well as smaller tokens BRL1, which is backed by a group that includes Brazilian exchanges Mercado Bitcoin and Bitso, and the Celo blockchain-native cREAL.
BRD is looking to distinguish itself as the first real-pegged token to explicitly structure the token to share the yield from the government debt backing with holders.
It is not, however, alone. Brazilian startup Crown raised $13.5 million in a series A round led by Paradigm in December for a similar yield-bearing token, BRLV. That token, according to a website dedicated to it, has around $19 million worth of reals in circulation. The listed contract addresses show it has just two holders.
BrazilStablecoinsYield
More For You
KuCoin Hits Record Market Share as 2025 Volumes Outpace Crypto Market
Commissioned byKuCoin
KuCoin captured a record share of centralised exchange volume in 2025, with more than $1.25tn traded as its volumes grew faster than the wider crypto market.
What to know:
- KuCoin recorded over $1.25 trillion in total trading volume in 2025, equivalent to an average of roughly $114 billion per month, marking its strongest year on record.
- This performance translated into an all-time high share of centralised exchange volume, as KuCoin’s activity expanded faster than aggregate CEX volumes, which slowed during periods of lower market volatility.
- Spot and derivatives volumes were evenly split, each exceeding $500 billion for the year, signalling broad-based usage rather than reliance on a single product line.
- Altcoins accounted for the majority of trading activity, reinforcing KuCoin’s role as a primary liquidity venue beyond BTC and ETH at a time when majors saw more muted turnover.
- Even as overall crypto volumes softened mid-year, KuCoin maintained elevated baseline activity, indicating structurally higher user engagement rather than short-lived volume spikes.
View Full Report
More For You
Babylon Labs raises $15 million from a16z crypto to develop Bitcoin collateral infrastructure
Funding will be used to build and scale Babylon Trustless BTCVaults, enabling native bitcoin to be used as onchain collateral without custodians or wrapping.
What to know:
- Babylon Labs has raised $15 million from a16z crypto, which purchased that amount of the platform’s BABY token.
- The capital will fund the development and scaling of Babylon Trustless BTCVaults.
- BABY surged 13% on the news.
Read full story
Latest Crypto News
Filecoin declines as crypto markets retreat
CoinDesk 20 Performance Update: Uniswap (UNI) Falls 1.5% as Index Trades Lower
Rumble introduces crypto wallet with Tether, allowing tips in BTC, USDT, XAUT
Babylon Labs raises $15 million from a16z crypto to develop Bitcoin collateral infrastructure
Ripple again rules out IPO, saying balance sheet gives it room to stay private
Strategy’s STRC perpetual preferred stock returns to $100, may trigger more bitcoin buying
Top Stories
Crypto Markets Today: Bitcoin slides as Asia-led sell-off hits altcoins
Morgan Stanley files for ether trust after bitcoin and solana ETF push
Ripple again rules out IPO, saying balance sheet gives it room to stay private
Bitcoin miners chase AI demand as Nvidia says Rubin is already in production
XRP could outperform bitcoin as XRP/BTC chart shows rare Ichimoku breakout since 2018
Start-of-the-year recovery rally stalls: Crypto Daybook Americas
Market Opportunity
Lorenzo Protocol Price(BANK)
$0.05395
$0.05395$0.05395
USD
Lorenzo Protocol (BANK) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
You May Also Like
Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking
U.S. President Donald Trump filed a lawsuit against JPMorgan Chase and its CEO Jamie Dimon personally, accusing the institution of deliberate debanking. The politician
Share
Incrypted2026/01/23 15:59
Here’s why Polygon price is at risk of a 25% plunge
Polygon price continued its freefall, reaching its lowest level since April 21, as the broader crypto sell-off gained momentum. Polygon (POL) dropped to $0.1915, down 32% from its highest point in May and 74% below its 2024 peak. The crash…
Share
Crypto.news2025/06/19 00:56
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution
The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26